Opinion

Amol Akhade Shared Key Lung Cancer Trials from ASCO 2025

Amol Akhade/hiranandanihospital.org

May 20, 2025, 07:14

Amol Akhade Shared Key Lung Cancer Trials from ASCO 2025

Amol Akhade, Consultant Medical Oncologist at the Suyog Cancer Clinics, shared a post on X:

“Thoracic Oncologists – Siena is here

Don’t feel sad as ASCO 2025 has no lung cancer plenary. But these lung cancer trials are unmissable:

CheckMate 77T – Periop nivo shines in resectable NSCLC

KRYSTAL-7 – Adagrasib + pembro in KRAS G12C

DeLLphi-304 – Tarlatamab moves the needle in SCLC

SACHI – Savolitinib + osimertinib hits MET

Plus: MRD, ctDNA, and chronotherapy updates Watch out Siena below

She is there only for Thoracic oncologist”

Proceed to the video attached to the post.

More posts featuring Amol Akhade on OncoDaily.

Adagrasib Amol Akhade ASCO 2025 cancer CheckMate-77T chronotherapy ctDNA DeLLphi-304 KRAS G12C KRYSTAL-7 Lung cancer MET MRD NSCLC OncoDaily Oncology osimertinib pembrolizumab perioperative immunotherapy SACHI Savolitinib SCLC Tarlatamab Thoracic Oncology

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

Arnaud Lallouette: Servier and IDEAYA Partner to Bring a Promising Uveal Melanoma Treatment

100 Oncologists, One Community: Reflections from the First ESO College Convention

Gevorg Tamamyan: "Fertility News" is on the Way

JCO on a Jamaican Beach: The Journey of Joyson Karakunnel